Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.

Roughly one in eight Americans say they are taking a GLP-1 drug -- and not just for weight loss. Studies have shown it can help heart disease, sleep apnea, addiction and even brain health. We speak ...

Personal and small business cards issued by Bank of America are currently not available on CNBC Select and links have been redirected to our credit card marketplace, where you can review offers from ...

While some question the authenticity of this individual, every gamer has encountered or embodied the spirit of a Marathon Steve at some point in their gaming journey.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Doug Mahoney Doug Mahoney is a writer covering home-improvement topics, ...

Get ready for your aha moment: Every weekday, host Meghna Chakrabarti pierces your news bubble to expose the whole story. Getting answers to the questions that need to be asked, examining our history ...